Skip to main content

Table 1 Summary of the ATP III and IDF criteria for MetS

From: The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

  ATP III (3 of 5) IDF (2 of 4, central obesity is mandatory)
Waist circumference Abdominal obesity, based on waist circumference > 102 cm for men, and > 88 cm for women Central obesity based on ethnicity specific valuesa (for Europids: waist circumference ≥ 94 cm for men, and ≥ 80 cm for women).
Triglycerides ≥ 150 mg/dL ≥ 150 mg/dL, or specific treatment for this lipid abnormality.
HDL cholesterol <  40 mg/dL for men
<  50 mg/dL for women
<  40 mg/dL for men, <  50 mg/dL for women, or specific treatment for this lipid abnormality.
Blood pressure (BP) ≥ 130/ ≥85 mmHg Systolic BP ≥ 130 mmHg, or diastolic BP ≥ 85 mmHg, or treatment of previously diagnosed hypertension.
Fasting glucose ≥ 110 mg/dL ≥ 100 mg/dL, or previously diagnosed type 2 diabetes mellitus.
  1. aEuropean measures were used due to the lack of regional standards. ATP III: Adult Treatment Panel III. IDF: International Diabetes Federation. MetS: Metabolic syndrome. HDL: High-density lipoproteins